%0
Generic
%T
Repurposing bromocriptine for Aβ metabolism in Alzheimer’s disease (REBRAnD) study: randomised placebo-controlled double-blind comparative trial and open-label extension trial to investigate the safety and efficacy of bromocriptine in Alzheimer’s disease with presenilin 1 (PSEN1) mutations
%A Kondo, Takayuki
%A Banno, Haruhiko
%A Okunomiya, Taro
%A Amino, Yoko
%A Endo, Kayoko
%A Nakakura, Akiyoshi
%A Uozumi, Ryuji
%A Kinoshita, Akemi
%A Tada, Harue
%A Morita, Satoshi
%A Ishikawa, Hidehiro
%A Shindo, Akihiro
%A Yasuda, Ken
%A Taruno, Yosuke
%A Maki, Takakuni
%A Suehiro, Takashi
%A Mori, Kohji
%A Ikeda, Manabu
%A Fujita, Koji
%A Izumi, Yuishin
%A Kanemaru, Kazutomi
%A Ishii, Kenji
%A Shigenobu, Kazue
%A Kutoku, Yumiko
%A Sunada, Yoshihide
%A Kawakatsu, Shinobu
%A Shiota, Shunji
%A Watanabe, Toshifumi
%A Uchikawa, Osamu
%A Takahashi, Ryosuke
%A Tomimoto, Hidekazu
%A Inoue, Haruhisa
%I BMJ
%@ 2044-6055
%K General Medicine
%D 2021
%C BMJ
%U http://slubdd.de/katalog?TN_libero_mab2